Patents matching “inhibitor”

US 6103711

Inhibitors of interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Aug 15, 2000 · Expires Aug 10, 2020

US 6100254

Inhibitors of protein tyrosine kinases

The Board of Regents of the University of Texas System · Granted Aug 8, 2000 · Expires Aug 3, 2020

US 6090840

Peptidyl compounds having MMP and TNF inhibitory activity

Darwin Discovery Limited · Granted Jul 18, 2000 · Expires Jul 13, 2020

US 6087384

Apoptosis inhibitor

Takeda Chemical Industries Ltd. · Granted Jul 11, 2000 · Expires Jul 6, 2020

US 6084063

Signal transduction inhibitors of allergic reactions

The United States of America, as represented by the Department of Health and Human Services · Granted Jul 4, 2000 · Expires Jun 29, 2020

US 6075044

Heterocyclic derivatives as inhibitors of purine salvage phosphoribosyltransferases

The Regents of the University of California · Granted Jun 13, 2000 · Expires Jun 8, 2020

US 6075014

Inhibitors of .beta.-lactamases and uses therefor

Northwestern University · Granted Jun 13, 2000 · Expires Jun 8, 2020

US 6071949

Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 6, 2000 · Expires Jun 1, 2020

US 6071509

Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor

Maxim Pharmaceuticals, Inc. · Granted Jun 6, 2000 · Expires Jun 1, 2020

US 6069130

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. · Granted May 30, 2000 · Expires May 25, 2020

US 6063794

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted May 16, 2000 · Expires May 11, 2020

US 6063373

Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor

Maxim Pharmaceuticals, Inc. · Granted May 16, 2000 · Expires May 11, 2020

US 6060310

Transcription factor decoy and tumor growth inhibitor

The United States of America, as represented by the Department of Health and Human Services · Granted May 9, 2000 · Expires May 4, 2020

US 6060500

Suppression, by 5-lipoxygenase inhibitors, of bone resorption

The Board of Regents of the University of Texas System · Granted May 9, 2000 · Expires May 4, 2020

US 6054472

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated · Granted Apr 25, 2000 · Expires Apr 20, 2020

US 6046169

Inhibitors of factor XA

COR Therapeutics, Inc. · Granted Apr 4, 2000 · Expires Mar 30, 2020

US 6046175

Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 4, 2000 · Expires Mar 30, 2020

US 6040340

Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors

The Board of Regents, Univ. of Texas System · Granted Mar 21, 2000 · Expires Mar 16, 2020

US 6040334

Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 21, 2000 · Expires Mar 16, 2020

US 6034255

Inhibitors of cholesterol esterase

The Regents of the University of New Mexico · Granted Mar 7, 2000 · Expires Mar 2, 2020

US 6025147

Inhibitors of interleukin-1 .beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Feb 15, 2000 · Expires Feb 10, 2020

US 6022861

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Feb 8, 2000 · Expires Feb 3, 2020